---
figid: PMC9563854__fmolb-09-978375-g003
figtitle: Natural antisense transcripts as drug targets
organisms:
- Influenza A virus
- Human alphaherpesvirus 1
- unidentified influenza virus
- Adeno-associated virus
- adeno-associated virus 2
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Drosophila melanogaster
pmcid: PMC9563854
filename: fmolb-09-978375-g003.jpg
figlink: /pmc/articles/PMC9563854/figure/F3/
number: F3
caption: Post-transcriptional biological processes regulated by NATs. (i) miRNA sponging.
  NATs regulate mRNA degradation by sponging miRNA or blocking miRNA binding sites.
  (ii) Regulation of mRNA stability. NATs sponge proteins regulating mRNA degradation
  and stability. (iii) MIR-NAT-mediated translation repression. MIR-NATs overlapping
  5′UTRs head-to-head compete with IRES for 40S ribosome subunit and repress translation.
  (iv) SINEUPs modulating translation initiation. The binding domain of SINEUP overlaps
  the translation initiation site and the effector domain recruits proteins (such
  as PTBP1) mediating assembly of translation initiation complex (TIC), resulting
  in translation upregulation. (v) Regulation by NAT-encoded mini-proteins. NATs can
  encode short peptides with downstream regulatory functions. (vi) Regulation of protein
  stability. NATs protect target proteins from degradation by sponging/inhibiting
  activity of proteins involved in ubiquitin-proteosome degradation pathway (such
  as SMURF1/2, MDM2). (vii) Protein translocation. NATs modulate subcellular distribution
  of proteins. UTR, untranslated region; CDS, coding sequence; MIR-NAT, mammalian-wide
  interspersed repeat natural antisense transcript; IRES, internal ribosome entry
  site; HuR, Hu-antigen R/ELAV-like RNA-binding protein 1; SINEUP, inverted SINEB2
  sequence-mediated upregulating molecules; TIC, translation initiation complex; PTBP1,
  polypyrimidine tract binding protein-1; TIS, translation initiation site; USP14,
  ubiquitin-specific protease 14; SMURF1/2, SMAD-specific E3 ubiquitin protein ligase
  1; MDM2, MDM2 proto-oncogene.
papertitle: Natural antisense transcripts as drug targets.
reftext: Olga Khorkova, et al. Front Mol Biosci. 2022;9:978375.
year: '2022'
doi: 10.3389/fmolb.2022.978375
journal_title: Frontiers in Molecular Biosciences
journal_nlm_ta: Front Mol Biosci
publisher_name: Frontiers Media S.A.
keywords: natural antisense transcript (NAT) | long nocoding RNA | anisense oligonucleotides
  | posttranscriptional regulation | nucleic acid based therapeutics
automl_pathway: 0.9135892
figid_alias: PMC9563854__F3
figtype: Figure
redirect_from: /figures/PMC9563854__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9563854__fmolb-09-978375-g003.html
  '@type': Dataset
  description: Post-transcriptional biological processes regulated by NATs. (i) miRNA
    sponging. NATs regulate mRNA degradation by sponging miRNA or blocking miRNA binding
    sites. (ii) Regulation of mRNA stability. NATs sponge proteins regulating mRNA
    degradation and stability. (iii) MIR-NAT-mediated translation repression. MIR-NATs
    overlapping 5′UTRs head-to-head compete with IRES for 40S ribosome subunit and
    repress translation. (iv) SINEUPs modulating translation initiation. The binding
    domain of SINEUP overlaps the translation initiation site and the effector domain
    recruits proteins (such as PTBP1) mediating assembly of translation initiation
    complex (TIC), resulting in translation upregulation. (v) Regulation by NAT-encoded
    mini-proteins. NATs can encode short peptides with downstream regulatory functions.
    (vi) Regulation of protein stability. NATs protect target proteins from degradation
    by sponging/inhibiting activity of proteins involved in ubiquitin-proteosome degradation
    pathway (such as SMURF1/2, MDM2). (vii) Protein translocation. NATs modulate subcellular
    distribution of proteins. UTR, untranslated region; CDS, coding sequence; MIR-NAT,
    mammalian-wide interspersed repeat natural antisense transcript; IRES, internal
    ribosome entry site; HuR, Hu-antigen R/ELAV-like RNA-binding protein 1; SINEUP,
    inverted SINEB2 sequence-mediated upregulating molecules; TIC, translation initiation
    complex; PTBP1, polypyrimidine tract binding protein-1; TIS, translation initiation
    site; USP14, ubiquitin-specific protease 14; SMURF1/2, SMAD-specific E3 ubiquitin
    protein ligase 1; MDM2, MDM2 proto-oncogene.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BMAL1
  - PSD4
  - BRD2
  - ELAVL1
  - SMURF2
  - SMURF1
  - USP14
  - USP1
  - USP2
  - USP3
  - USP4
  - USP5
  - USP6
  - USP7
  - USP8
  - USP10
  - USP11
  - USP12
  - USP13
  - USP15
  - USP16
  - USP18
  - USP19
  - USP20
  - USP21
  - USP22
  - USP24
  - USP25
  - USP26
  - USP27X
  - USP28
  - USP29
  - USP30
  - USP31
  - USP32
  - USP33
  - USP34
  - USP35
  - USP36
  - USP37
  - USP38
  - USP39
  - USP40
  - USP41P
  - USP42
  - USP43
  - USP44
  - USP45
  - USP46
  - USP47
  - USP48
  - USP49
  - USP50
  - USP51
  - PAN2
  - USP53
  - USP54
  - USP9X
  - USP9Y
  - USPL1
  - CYLD
  - USP17L1
  - USP17L2
  - SLURP1
  - MDM2
  - Brd2
  - Scn11a
  - Pdcd4
  - Elavl1
  - Smurf2
  - Usp14
  - Ttn
  - Mdm2
  - Nat1
  - ww
  - Tmc
  - Cds
  - cd-s
  - cos
  - Pka-C1
  - Pka-R2
  - Smurf
  - usp
  - EcR
  - vi
  - Sh
  - ple
  - Eig71Ee
  - l(2)46Da
  - anon-48Ae
---
